
Micro-Machined : Single or multiple layers of micro-machined high performance films are combined to created the tissue engineering biomaterial. The micro-machined layers can have similar or different patterns to create gradients.
Uniformly Strong : Ideal three-dimensional micro-machined scaffolds have a combination of mechanical strength and interconnected channels1. The tissue engineering biomaterial has been developed to optimize cellular environments with the requisite mechanical properties.
Interconnectivity : Controlled
interconnectivity, dependable results, and a consistent biologic response
are the result of well-characterised biomaterials generated through
a CAD-CAM process.
Biocompatible : The technology affords low levels of residual solvents and processing agents. Cellular reaction is more predictable with improved biocompatibility.
Quality : Service is performed in a controlled environment to ISO 13485:2003 standards to facilitate the transition into the clinical setting.
Translational : Proxy Biomedical
is committed to assisting in translational research and development of
tissue engineering biomaterial based products in a quality-controlled environment.
1. Yang, S. et al., “The Design of Scaffolds for Use in Tissue Engineering. Part I. Traditional Factors, #8221; Tissue Engineering (2001); 7(6): 679-689.
A variety of absorbable biomaterials with different degradation
profiles and non-absorbable biomaterials can be used to create the
MotifMESH Tissue Engineering Biomaterial. Biomaterials
with a history of clinical use can be the used, or new
and proprietary
biomaterials can be used. In addition, the biomaterials can
be elastic or inelastic depending on the biomaterial and processing
techniques employed.
Tissue engineering biomaterials with high-resolution features can be produced. Configurations that can be produced include unique shapes and tubular constructs formed to customer requirements.
Proxy Biomedical is interested in working with corporate and
institutional
partners on applications that leverage our core capabilities.
Our objective is to get products into the clinical setting with
partners by providing a state of the art research and development
service for tissue engineering biomaterials.